RegMedNet
@RegMedNet
Part of Taylor & Francis, features the latest news, opinions, insight and more on #regenerativemedicine, #cellandgenetherapy in partnership with @Regen_Med
What are the key challenges in developing and manufacturing iPSCs and MSCs? This infographic breaks them down. Discover the biological hurdles that impact fundamental cellular properties. Download now >>> hubs.ly/Q03sT_N30 @SartoriusGlobal

Breaking the bottleneck in cell therapy manufacturing! This Application Note shows how to transition MSC production from labor-intensive 2D culture to efficient 3D suspension bioreactors. Download now to learn how the @SartoriusGlobal MSC Pilot Solution can result in higher cell…

In this eBook, sponsored by @Eppendorf_Group, we dive into the applications of CAR-T therapies for T-cell malignancies and lymphoblastic leukemia/lymphoma. Download now and dive into journal content, white papers and more >>> hubs.ly/Q03x29Q-0

Check out this column exploring how private equity and venture capital firms are fueling both scientific innovation and commercial development of cell and gene therapies. hubs.ly/Q03xsKM70

Introducing our In Focus feature on iPSCs and MSCs. We've teamed up with @SartoriusGlobal to compare iPSCs and MSCs in regenerative medicine. Discover their unique therapeutic potential and the challenges researchers face in their development >>> hubs.ly/Q03sTRzD0
Don't miss our interview with @SartoriusGlobal’ Process Development Scientist, Alyssa Clearwood, on cell therapy development and manufacturing. We explore the technical and regulatory challenges that arise when working with iPSCs and MSCs >>> hubs.ly/Q03sV3D10

[eBook] CAR-T therapy: from laboratory optimization to clinical application! Browse through resources from @Eppendorf_Group alongside articles from our partnered journals for an overview of the field’s current status and future directions >>> hubs.ly/Q03x2d220
![RegMedNet's tweet image. [eBook] CAR-T therapy: from laboratory optimization to clinical application! Browse through resources from @Eppendorf_Group alongside articles from our partnered journals for an overview of the field’s current status and future directions >>> hubs.ly/Q03x2d220](https://pbs.twimg.com/media/Gv1FNoZWMAABUNb.png)
[Application Note] Learn how researchers successfully scaled mesenchymal stem cell production from 2D to 3D culture using @SartoriusGlobal's MSC Pilot Solution >>> hubs.ly/Q03sSV7J0
![RegMedNet's tweet image. [Application Note] Learn how researchers successfully scaled mesenchymal stem cell production from 2D to 3D culture using @SartoriusGlobal's MSC Pilot Solution >>> hubs.ly/Q03sSV7J0](https://pbs.twimg.com/media/GvkZtVAXMAEPAJy.jpg)
Discover an integrated workflow for iPSC culture & characterization! In this Application Note, @SartoriusGlobal introduces how CellCelector Flex, Incucyte® & iQue® platforms work together to maintain pluripotency with minimal sample volumes >>> hubs.ly/Q03sSWlp0

This week, in cell and gene therapy: 👉 Mustang Bio’s targeted CART-cell therapy, MB-101, received an Orphan Drug Designation 🧬 Lexeo Therapeutics’ gene therapy for Friedreich Ataxia, LX2006, was granted Breakthrough designation 🤝 Amarna Therapeutics and NorthX Biologics made…

What are the critical hurdles that arise during the development and manufacturing of iPSCs and MSCs? Find out the transformative potential of iPSCs and MSCs in regenerative medicine and cell therapy >>> hubs.ly/Q03sTPGV0 @SartoriusGlobal
This week, in cell and gene therapy: 👉 The FDA removed the Risk Evaluation and Mitigation Strategies (REMS) for six currently approved CAR-T cell therapies 👂A Karolinska Institutet study reports positive data on gene therapy for congenital hearing loss ✅ @RinriTx has been…
Our Commissioning Editor Jasmine Hagan spotlights groundbreaking research from Regenerative Medicine's latest issues. Read her highlights, including: 🧬 Gene therapy breakthroughs for Charcot-Marie-Tooth disease ❤️ Neonatal heart regeneration mechanisms with translational…

In this interview, Alyssa Clearwood, Process Development Scientist at @SartoriusGlobal, gives her insight into how cell therapy developers and manufacturers can navigate the technical and regulatory challenges that arise when working with iPSCs and MSCs >>>…

In this Application Note, @SartoriusGlobal showcases how to maintain healthy iPSCs using an integrated workflow with three key Sartorius platforms. Overcome traditional challenges with automated solutions that deliver consistency and reproducibility >>> hubs.ly/Q03sSWdQ0

We want to hear from you! We’re shining a #spotlight on plasmid analysis and quality control. Take the survey and share your experience in plasmid-based cell and gene therapy manufacturing >>> hubs.ly/Q03hPZv60
The genetic mechanisms behind liver regeneration have been revealed, including interplay between regeneration-specific enhancers and reactivated developmental enhancers >>> hubs.ly/Q03twjHG0

Scaling cell therapy manufacturing? In this Application Note, @SartoriusGlobal demonstrates the successful transition from 2D to 3D expansion of MSCs using the Sartorius MSC Pilot Solution. See how Univessel® bioreactors outperform traditional methods while maintaining critical…

In this Spotlight eBook, we bring together leading voices in gene therapy testing, offering practical insights and visual guides to help you navigate complex testing processes for plasmid-based therapeutics. Download for more >>> hubs.ly/Q03pdwb50
This month we’re putting iPSCs and MSCs #InFocus! What are the similarities and differences between these two key stem cell types? Find out in this In Focus, sponsored by @SartoriusGlobal >>> hubs.ly/Q03sTRv20